Related Experiment Video
Updated: Jul 25, 2026

Early Detection of Drug-Induced Renal Hemodynamic Dysfunction Using Sonographic Technology in Rats
Published on: March 11, 2016
Dasatinib-Induced Nephrotic Syndrome: A Case Report.
Ahmed ElShaer1, Mazen Almasry1, Maher Alawar2
1Internal Medicine, Alfaisal University College of Medicine, Riyadh, SAU.
Second-generation tyrosine kinase inhibitors (TKIs) like dasatinib can cause rare kidney problems in chronic myeloid leukemia (CML) patients. This case highlights nephrotic syndrome, which resolved after switching to nilotinib.
Area of Science:
- Oncology
- Nephrology
- Pharmacology
Background:
- Second-generation tyrosine kinase inhibitors (TKIs), including dasatinib and nilotinib, are crucial in treating chronic myeloid leukemia (CML).
- While generally safe, these TKIs are associated with adverse events like pulmonary hypertension and cardiovascular issues.
- Renal complications are infrequently reported with TKI therapy.
Related Concept Videos
Nephrotic Syndrome I : Introduction
Nephrotic Syndrome II : Assessment and Medical Management
Nephrotic Syndrome III : Nursing Management
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease II: Clinical Manifestations
Diabetic Nephropathy

